Jacques Walker

Nanocan Therapeutics Corporation is an early-stage biotechnology company that develops nanotechnology-based innovations to treat cancers where current interventions are insufficient. The company is based in Princeton, NJ. The company aims to create a new standard of care for cancer patients through its partnerships with leading academic research institutions. Nanocan is committed to making its disruptive innovations available to cancer patients in low and middle-income countries. The company was founded by Jacques Walker and Eric Broyles, and Eric Broyles has been the CEO since incorporation.

Nanocan Therapeutics Corporation is an early-stage biotechnology company that develops nanotechnology-based innovations to treat cancers where current interventions are insufficient. The company is based in Princeton, NJ. The company aims to create a new standard of care for cancer patients through its partnerships with leading academic research institutions. Nanocan is committed to making its disruptive innovations available to cancer patients in low and middle-income countries. The company was founded by Jacques Walker and Eric Broyles, and Eric Broyles has been the CEO since incorporation.